Distinguished Leader Award: Kirk N. Campbell, MD, FASN

Kirk N. Campbell
Search for other papers by Kirk N. Campbell in
Current site
Google Scholar
Full access

Kirk N. Campbell, MD, FASN

Citation: Kidney News 14, 10/11

Dr. Campbell is the Irene and Dr. Arthur M. Fishberg Professor of Medicine at the Icahn School of Medicine at Mount Sinai in New York City, where he is also director of the Nephrology Fellowship Program and vice chair for diversity, equity, and inclusion in the Department of Medicine. He co-chairs the ASN Kidney Week 2022 Education Committee.

Dr. Campbell leads a National Institutes of Health (NIH)-funded research program focused on podocyte cell biology, experimental glomerular disease, and clinical trials in rare kidney diseases. The work centers on understanding the underlying mechanisms of glomerular disease progression and identifying targets for therapeutic intervention. He has been a principal investigator for clinical trials, testing novel agents for focal segmental glomerulosclerosis, IgA nephropathy, lupus nephritis, and membranous nephropathy.

He is a member of the editorial boards of Kidney360, Kidney International, American Journal of Kidney Diseases, Frontiers in Medicine, and American Journal of Physiology−Renal Physiology.

As director of the Nephrology Fellowship Program, he helped expand research training opportunities and established new subspecialty training tracks in critical care nephrology, geriatric nephrology, and home dialysis.

A former president of The New York Society of Nephrology, Dr. Campbell is a member of the Board of Directors of the NephCure Foundation, the Medical Advisory Board of the National Kidney Foundation Serving Greater New York, and the NIH Pathobiology of Kidney Disease study section. He has served ASN on the Diversity, Equity, and Inclusion Committee; Grants Review Committee; and Continuous Professional Development Committee. He is a member of the American Kidney Fund's Health Equity Coalition Subgroup focused on advancing strategies for inclusive clinical trial enrollment.

Dr. Campbell received his medical degree from the University of Connecticut, did his residency at Yale University, and completed his nephrology fellowship at the Icahn School of Medicine at Mount Sinai.